Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1546817

registered interest
date	30/11/2022
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Energy Bills Rebate: District Heating and Park Homes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will set out the mechanism for receipt of support through the Energy Bill Relief Scheme for (a) persons whose energy is supplied as part of a heat network and (b) residents of park homes.
tabling member constituency	Darlington
tabling member printed	Peter Gibson
uin	99990
answer	answer is ministerial correction date of answer 08/12/2022 answer text <p>Heat network suppliers and park home site owners who are supported by the Energy Bill Relief Scheme (EBRS) are required to pass this support on, in a just and reasonable way, to end users.</p><p> </p><p>This is set out in legislation. Full guidance on the mechanism for passing through this support is set out in the <a href="https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fpass-through-requirements-for-energy-price-support-provided-to-intermediaries%2Fguidance-on-the-pass-through-requirements-for-energy-price-support-in-great-britain-provided-to-intermediaries&amp;data=05%7C01%7CParliamentary.PQ%40BEIS.gov.uk%7C45786599200d47eabb5408dad931c658%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C638061105039324824%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=%2FqyVnPiPerw%2Bhgt6HPdHg37PlgmYZxQPEhMjH66WuS4%3D&amp;reserved=0" target="_blank">scheme guidance</a>.</p> answering member constituency Beverley and Holderness answering member printed Graham Stuart question first answered 08/12/2022 17:03:10 answering member 1482 label Biography information for Graham Stuart
tabling member	4754 label Biography information for Peter Gibson

1547041

registered interest
date	30/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clozapine: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has provided to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Clozapine is not misused in patients who consume alcohol or smoke while being prescribed that drug.
tabling member constituency	Darlington
tabling member printed	Peter Gibson
uin	99991
answer	answer is ministerial correction date of answer 07/12/2022 answer text <p>No specific guidance has been issued.</p><p> </p><p>The product information for clozapine for healthcare professionals and patients advises against drinking alcohol during treatment with that drug. The Medicines and Healthcare products Regulatory Agency provided a Drug Safety Update which recommends that blood concentration of clozapine should be monitored for toxicity in clinical situations, such as during smoking cessation or if a patient transfers to e-cigarettes. The British National Formulary advises that dose adjustment may be necessary if a patient’s smoking habits change during treatment with clozapine.</p> answering member constituency Colchester answering member printed Will Quince question first answered 07/12/2022 14:36:34 answering member 4423 label Biography information for Will Quince
tabling member	4754 label Biography information for Peter Gibson

1547043

registered interest
date	30/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregabalin: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance has been issued to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Pregabalin is not misused in patients who consume alcohol and smoke while being prescribed that drug.
tabling member constituency	Darlington
tabling member printed	Peter Gibson
uin	99992
answer	answer is ministerial correction date of answer 08/12/2022 answer text <p>No specific guidance has been issued. Pregabalin is a controlled substance and the British National Formulary states that healthcare professionals should evaluate patients for a history of drug misuse before prescribing pregabalin and observe patients for the development of signs of misuse and dependence.</p> answering member constituency Colchester answering member printed Will Quince question first answered 08/12/2022 14:36:02 answering member 4423 label Biography information for Will Quince
tabling member	4754 label Biography information for Peter Gibson